RPE65 and Leber congenital amaurosis: Analyzing the morphological features emerging from the above clinical tests, we can hypothesize that patients with LCA related to RPE65 gene mutation, who present morphological features at ERG of extinction but preserved retina on OCT, may benefit more from gene therapy with Luxturna than patients who present retinal morphological features now deteriorated at both ERG and OCT.